Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
AI workspace for life-sciences medical, legal, and regulatory (MLR) review of promotional and marketing content.
Revisto, founded in 2023 and headquartered in Austin, Texas, provides a purpose-built AI workspace for life-sciences marketing and medical/legal/regulatory (MLR) review teams, integrating with existing promotional-content workflows to help identify and manage claims, references, and compliance issues in marketing materials. The company reports roughly $6M raised, including a 2024 seed round led by LiveOak Ventures with participation from Eli Lilly. Atlas found no vendor-held security certifications documented on its site.
57% — Partial coverage. Coverage score — how completely Atlas documents Revisto across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Biotech Startup, Mid-Size Biotech, Large Pharma, Top 20 Pharma, Commercial, Regulatory Affairs
Natural Language Processing
Seed, $6.0M raised, Founded 2023
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?